Rapidly expanding right coronary artery aneurysm.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Paolo Stassano.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Hypertrophic obstructive cardiomyopathy is a dynamic obstruction of the left ventricular outflow tract caused by septal hypertrophy and systolic anterior motion of the mitral valve. When the condition cannot be controlled by medical therapy the most frequently used surgical approach is left ventricular myotomy-myectomy. Mitral valve replacement (to correct another mechanism of obstruction) is another surgical option; however, its use for this condition is controversial. We review the long-term results of patients who underwent limited left ventricular myotomy-myectomy and mitral valve replacement at our institution. Eighteen patients who had hypertrophic obstructive cardiomyopathy and severe mitral insufficiency underwent surgery between 1978 and 1983: 7 were men and 11 were women (mean age, 41.8 +/- 10.5 years). Preoperatively, most of the patients (78.8%) were in New York Heart Association functional class III or IV. The operation consisted of a shallow myectomy of the hypertrophied septum and mitral valve replacement. One patient died in the hospital (5.5%); 3 patients died later during follow-up. The remaining 14 patients are alive and in good condition (mean follow-up, 21.9 +/- 1.7 years). Functional class improved postoperatively in all surviving patients. The mean left ventricular outflow tract gradient fell from 78.1 +/- 20.9 mmHg preoperatively to 9.4 +/- 5.2 mmHg postoperatively (P <0.001). At present, surgical treatment of hypertrophic obstructive cardiomyopathy does not include mitral valve replacement. However, our long-term results show that limited ventricular myectomy and mitral valve replacement predictably and consistently lower the left ventricular outflow tract gradient and resolve the mitral valve insufficiency.
The nitinol TrapEase inferior vena cava filter is a new device for pulmonary embolism prophylaxis. No cases of filter migration or filter-related complications with this type of device have so far been described. We report a case of intracardiac migration of this filter in a patient with a patent foramen ovale, resulting in severe cardiogenic shock, cerebral and right arm paradoxical embolism. Surgical treatment, results, causes of these complications are discussed.